Fri, Dec 19, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Advent enters into agreement with SuperDerivatives to provide pricing and analytics services to Geneva clients

Friday, July 02, 2010
Opalesque Industry Update - Advent Software, Inc., a leading provider of software and services for the global investment management industry, today announced that it has entered into an agreement with SuperDerivatives, Inc. to offer their multi-asset web analytic system and revaluation services to clients of Geneva®, its award-winning portfolio management and fund accounting solution.

SuperDerivatives is a leading derivatives solution provider. It provides real-time pricing for simple and complex derivatives instruments through its unique pricing models.  SuperDerivatives' products cover the spectrum of derivatives usage, including real-time pricing and analytics platforms, risk management systems, portfolio revaluation services, options market data portal and an online trading platform.

Advent will develop an integration accelerator based on the layouts, formats, and instrument constructs of the revaluation pricing services provided by SuperDerivatives.  The accelerator will enable clients to feed this data directly into the Geneva® application via Advent’s Workflow Manager Integration Tool.  In teaming with SuperDerivatives, Advent will be able to offer clients a single cost-effective, automated interface for providing OTC derivatives pricing data into Geneva®.

“Advent is very pleased to provide our Geneva® customers a turnkey pre-integrated revaluation solution through this new relationship with SuperDerivatives,” said Chris Momsen, Senior Vice President and General Manager of Global Accounts at Advent. “This marks another step in our efforts to continue building out middle-office functionality in Geneva®, and demonstrates our ongoing commitment to delivering further value for our clients.”

Zohar Hod, Senior Vice President for Business Development and Strategic Sales at SuperDerivatives, commented, “We are delighted to be working with Advent; our web analytic application and revaluation service for derivatives are ideally suited to the needs of their Geneva® client base comprised of hedge funds, asset managers, prime brokers, and fund administrators.  SuperDerivatives' accurate pricing and valuation for the broadest range of OTC derivatives combined with the Geneva® platform, will deliver the optimal derivatives management tool for their clients.” Corporate website: Source

- FG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und